AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2,169 Cr |
| Mar2024 | ₹-1,021 Cr |
| Mar2023 | ₹223 Cr |
| Mar2022 | ₹-1,164 Cr |
| Mar2021 | ₹2,563 Cr |
How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,169 Cr | Positive | |
| Mar2024 | ₹-1,021 Cr | Negative | |
| Mar2023 | ₹223 Cr | Positive | |
| Mar2022 | ₹-1,164 Cr | Negative | |
| Mar2021 | ₹2,563 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹69,608.9 Cr | -0.7% | 2.3% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.7% |
2.3% |
-6.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses